Skip to main content
Clinical Trials/NCT06728501
NCT06728501
Completed
Not Applicable

Diabetes Education for Patients With Type 2 Diabetes in Turkmenistan

Ludwig-Maximilians - University of Munich1 site in 1 country114 target enrollmentFebruary 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment
114
Locations
1
Primary Endpoint
Change in HbA1c
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of the study is to investigate whether structured diabetes mellitus education leads to improved blood glucose control in Turkmenistan.

Detailed Description

Diabetes education is not routinely carried out in Turkmenistan. The aim of the study is to investigate whether patients with type 2 diabetes benefit from an International Diabetes Federation (IDF) based education program. Patients will be randomized into a education group and a control group. The education group will receive 4 - 5 hours of education and the control group will only receive general information about diabetes mellitus. After 6 months, it is checked whether the change in the HbA1c value differs between the two groups. Additinal paremeters such as blood pressure, diabetes knowledge and lipids will also be evaluated (secondary parameters).

Registry
clinicaltrials.gov
Start Date
February 1, 2022
End Date
July 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Klaus Parhofer

Prof of Endocrinology and Metabolism

Ludwig-Maximilians - University of Munich

Eligibility Criteria

Inclusion Criteria

  • type 2 diabetes

Exclusion Criteria

  • type 1 diabetes
  • diabetes duration \< 1 year
  • severe comorbidities
  • abuse of alcohol or drugs
  • pregnancy

Outcomes

Primary Outcomes

Change in HbA1c

Time Frame: 6 months

Study Sites (1)

Loading locations...

Similar Trials